Back to O& Oppenheimer & Co Inc
NVAX
Showing 8 of 27 quarters
Position history for O&Oppenheimer & Co Inc's holdings in Novavax, Inc.
Yes. Oppenheimer holds 57,949 shares of NVAX (Novavax), worth $626,429, as of its Q3 2026 13F filing. It reduced the position by 36,810 shares (-38.8%) from Q2 2026. Oppenheimer has held NVAX since Q1 2020, across 27 quarterly 13F filings.
Current Value
$626,429
Current Shares
57,949
Total Value Change
+$276,102
Total Shares Change
+14,376
Quarter-by-Quarter History